The US Food and Drug Administration has approved a supplemental new drug application for the use of a combination therapy to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and...
The US Food and Drug Administration has approved a supplemental new drug application for the use of a combination therapy to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and...
The US Food and Drug Administration has approved a supplemental new drug application for the use of a combination therapy to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and...
The US Food and Drug Administration has approved the first drug to slow the decline of kidney function in adults with a high risk of rapidly progressing autosomal dominant polycystic kidney disease.
The US Food and Drug Administration has approved the first drug to slow the decline of kidney function in adults with a high risk of rapidly progressing autosomal dominant polycystic kidney disease.
The US Food and Drug Administration has approved the first drug to slow the decline of kidney function in adults with a high risk of rapidly progressing autosomal dominant polycystic kidney disease.
Based on evidence from several clinical trials, an FDA advisory committee has voted unanimously to recommend the approval of a cannabis-based oral solution for the treatment of 2 rare forms of epilepsy.
...
